eMedicine Specialties > Gastroenterology > Systemic Disease
Familial Adenomatous Polyposis: Follow-up
Updated: Jul 30, 2008
Follow-up
Complications
- Colorectal cancer (100% in untreated patients)
- Duodenal or periampullary adenocarcinoma (4-12%)
- Desmoid formation (as many as 20%, typically postcolectomy)
- Other cancers include the following:
- Medulloblastoma
- Hepatoblastoma
- Thyroid cancer
- Gastric cancer
- Pancreatic cancer
- Adrenal cancer
- Development of rectal cancer in patients with a retained rectum
Prognosis
- Patients with untreated FAP have a median life expectancy of 42 years.
- Life expectancy is extended greatly in those treated with colectomy.
- Upper gastrointestinal cancers and desmoid tumors are the most common causes of death in patients who have undergone colectomy. This is why surveillance programs, especially after colectomy, are essential. Colectomy only addresses the risk of colon cancer development.
- The cumulative probability of developing any type of a noncolorectal cancer, mostly periampullary tumors, is 11% by age 50 years and 52% by age 75 years.
Patient Education
- Educate patients about the need for cancer surveillance after colectomy.
- Inform family members so that they may undergo screening.
Miscellaneous
Medicolegal Pitfalls
- Failure to adequately follow up and monitor for the development of other cancers (eg, rectal pouch, duodenum) may lead to legal problems. Surveillance programs are important.
- Offer genetic counseling before any genetic testing is performed. The patients and their family members should be made aware of the limitations of genetic testing and the associated consequences. Genetic counseling should be performed by someone familiar with FAP and the genetic tests available.
Special Concerns
- A gastroenterologist familiar with FAP should direct overall care.
- A geneticist is part of the medical team involved in therapy for FAP.
- Treatment frequently involves the input of a surgeon who is familiar with FAP.
More on Familial Adenomatous Polyposis |
| Overview: Familial Adenomatous Polyposis |
| Differential Diagnoses & Workup: Familial Adenomatous Polyposis |
| Treatment & Medication: Familial Adenomatous Polyposis |
Follow-up: Familial Adenomatous Polyposis |
| Multimedia: Familial Adenomatous Polyposis |
| References |
| « Previous Page | Next Page » |
References
Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A, et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. Feb 2008;6(2):215-9. [Medline].
Ponti G, Losi L, Pellacani G, Rossi GB, Presutti L, Mattioli F, et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Applied Immunohistochemistry & Molecular Morphology [serial online]. January 25, 2008;Available from: Pubmed. Accessed March 15, 2008. Available at http://www.appliedimmunohist.com/.
Bianchi LK, Burke CA, Bennett AE, et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. Feb 2008;6(2):180-5. [Medline].
Friederich P, van Heumen BW, Nagtegaal ID, et al. Increased epithelial cell proliferation in the ileal pouch mucosa of patients with familial adenomatous polyposis. Virchows Arch. Sep 2007;451(3):659-67. [Medline]. [Full Text].
Iaquinto G, Fornasarig M, Quaia M, et al. Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc. Jan 2008;67(1):61-7. [Medline].
Bresalier RS. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2006;2759-2810.
Brosens LA, Keller JJ, Offerhaus GJ, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut. Jul 2005;54(7):1034-43. [Medline].
Burke CA, Beck GJ, Church JM, et al. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc. Mar 1999;49(3 Pt 1):358-64. [Medline].
Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology. May 2005;128(6):1696-716. [Medline].
Bussey HJR. Genetic and epidemiological features of familial polyposis coli. In: Bussey HJR, ed. Familial Polyposis Coli. Baltimore, Md: Johns Hopkins University Press; 1975:9-17.
Doxey BW, Kuwada SK, Burt RW. Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol. Jul 2005;3(7):633-41. [Medline].
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. Feb 2006;101(2):385-98. [Medline].
Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. Mar 20 1997;336(12):823-7. [Medline].
Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. May 6 1993;328(18):1313-6. [Medline].
Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med. Apr 4 2002;346(14):1054-9. [Medline].
Schulmann K, Pox C, Tannapfel A, Schmiegel W. The patient with multiple intestinal polyps. Best Practice & Research Clinical Gastroenterology [serial online]. June 2007;21(3):409-426. Available from: Science Direct. Accessed June 2, 2008. Available at http://www.sciencedirect.com.
Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. Feb 20 2002;94(4):252-66. [Medline].
Zhang J, Ahmad S, Mao Y. BubR1 and APC/EB1 cooperate to maintain metaphase chromosome alignment. J Cell Biol. Aug 27 2007;178(5):773-84. [Medline].
Further Reading
Keywords
familial adenomatous polyposis, FAP, adenomatous polyposis syndrome, adenomatous polyps, colon cancer, colorectal cancer, adenomatous polyposis coli, colorectal carcinoma, colonic polyps, colonic neoplasia, rectal bleeding, adenomatous polyposis coli gene, APC gene, Gardner syndrome, Turcot syndrome, attenuated adenomatous polyposis coli, AAPC, desmoid tumors, intestinal polyposis, colectomy, rectal resection, duodenal adenocarcinoma, periampullary adenocarcinoma, medulloblastoma, hepatoblastoma, thyroid cancers, adrenal cancers, upper gastrointestinal cancers
Follow-up: Familial Adenomatous Polyposis